{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:43:10Z","timestamp":1791189790202,"version":"4.1.0"},"reference-count":41,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Cycle"],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.4161\/cc.21476","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T15:12:39Z","timestamp":1345043559000},"page":"3067-3078","source":"Crossref","is-referenced-by-count":79,"title":["E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73\/DNp73-miR-205 circuitry"],"prefix":"10.1080","volume":"11","author":[{"given":"Vijay","family":"Alla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani S.","family":"Kowtharapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Emmrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Steder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte M.","family":"P\u00fctzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"key":"R2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.191.6.1005","article-title":"Deregulated E2F transcriptional activity in autonomously growing melanoma cells","volume":"191","author":"Halaban","year":"2000","journal-title":"J Exp Med"},{"key":"R3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijc.11552","article-title":"Alterations of DeltaTA-p73 splice transcripts during melanoma development and progression","volume":"108","author":"Tuve","year":"2004","journal-title":"Int J Cancer"},{"key":"R4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnci\/djp458","article-title":"E2F1 in melanoma progression and metastasis","volume":"102","author":"Alla","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.cdd.4401205","article-title":"Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN\u2019-p73 transcript","volume":"10","author":"P\u00fctzer","year":"2003","journal-title":"Cell Death Differ"},{"key":"R6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.neo.7900237","article-title":"The human p73 promoter: characterization and identification of functional E2F binding sites","volume":"4","author":"Seelan","year":"2002","journal-title":"Neoplasia"},{"key":"R7","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1074\/jbc.M200480200","article-title":"Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis","volume":"277","author":"Stiewe","year":"2002","journal-title":"J Biol Chem"},{"key":"R8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-8-61","article-title":"Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo","volume":"8","author":"Emmrich","year":"2009","journal-title":"Mol Cancer"},{"key":"R9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6605204","article-title":"Role of miRNAs in the progression of malignant melanoma","volume":"101","author":"Mueller","year":"2009","journal-title":"Br J Cancer"},{"key":"R10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ng865","article-title":"Micro RNAs are complementary to 3\u2032 UTR sequence motifs that mediate negative post-transcriptional regulation","volume":"30","author":"Lai","year":"2002","journal-title":"Nat Genet"},{"key":"R11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-09-2721","article-title":"Melanoma MicroRNA signature predicts post-recurrence survival","volume":"16","author":"Segura","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R12","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1101\/gad.1706508","article-title":"Chromatin structure analyses identify miRNA promoters","volume":"22","author":"Ozsolak","year":"2008","journal-title":"Genes Dev"},{"key":"R13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Suzuki","year":"2009","journal-title":"Nature"},{"key":"R14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"R15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/82617","article-title":"Role of the p53-homologue p73 in E2F1-induced apoptosis","volume":"26","author":"Stiewe","year":"2000","journal-title":"Nat Genet"},{"key":"R16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1535-6108(03)00078-3","article-title":"Chemosensitivity linked to p73 function","volume":"3","author":"Irwin","year":"2003","journal-title":"Cancer Cell"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/sj.cdd.4401774","article-title":"TAp73\/DeltaNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma","volume":"12","author":"M\u00fcller","year":"2005","journal-title":"Cell Death Differ"},{"key":"R18","first-page":"3598","article-title":"Transactivation-deficient DeltaTA-p73 acts as an oncogene","volume":"62","author":"Stiewe","year":"2002","journal-title":"Cancer Res"},{"key":"R19","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1038\/sj.onc.1210337","article-title":"p63 and p73 in human cancer: defining the network","volume":"26","author":"Deyoung","year":"2007","journal-title":"Oncogene"},{"key":"R20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1101\/gad.252603","article-title":"Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells","volume":"17","author":"Jiang","year":"2003","journal-title":"Genes Dev"},{"key":"R21","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.2174\/092986711797189682","article-title":"Novel insights into targeting ATP-binding cassette transporters for antitumor therapy","volume":"18","author":"Gatti","year":"2011","journal-title":"Curr Med Chem"},{"key":"R22","first-page":"6693","article-title":"Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2","volume":"61","author":"Gomez-Manzano","year":"2001","journal-title":"Cancer Res"},{"key":"R23","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","article-title":"Novel genes associated with malignant melanoma but not benign melanocytic lesions","volume":"11","author":"Talantov","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R24","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","article-title":"Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy","volume":"22","author":"Yu","year":"2004","journal-title":"J Clin Oncol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1038\/cddis.2010.85","article-title":"Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells","volume":"1","author":"Bhatnagar","year":"2010","journal-title":"Cell Death Dis"},{"key":"R26","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1074\/jbc.M111.227611","article-title":"miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein","volume":"286","author":"Dar","year":"2011","journal-title":"J Biol Chem"},{"key":"R27","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1158\/0008-5472.CAN-07-5019","article-title":"Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer","volume":"67","author":"Sempere","year":"2007","journal-title":"Cancer Res"},{"key":"R28","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"R29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/cr.2009.18","article-title":"Suppression of cell growth and invasion by miR-205 in breast cancer","volume":"19","author":"Wu","year":"2009","journal-title":"Cell Res"},{"key":"R30","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-08-2920","article-title":"microRNA-205 regulates HER3 in human breast cancer","volume":"69","author":"Iorio","year":"2009","journal-title":"Cancer Res"},{"key":"R31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drup.2010.06.001","article-title":"Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance","volume":"13","author":"Engelmann","year":"2010","journal-title":"Drug Resist Updat"},{"key":"R33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1158\/1541-7786.MCR-09-0458","article-title":"Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells","volume":"8","author":"Hirano","year":"2010","journal-title":"Mol Cancer Res"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/1535-7163.MCT-11-0024","article-title":"ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance","volume":"10","author":"Millour","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"R35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1476-4598-9-314","article-title":"Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin","volume":"9","author":"Shukla","year":"2010","journal-title":"Mol Cancer"},{"key":"R36","first-page":"1332","article-title":"Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells","volume":"58","author":"Laing","year":"1998","journal-title":"Cancer Res"},{"key":"R37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/0008-5472.CAN-11-2575","article-title":"The dark side of E2F1: in transit beyond apoptosis","volume":"72","author":"Engelmann","year":"2012","journal-title":"Cancer Res"},{"key":"R38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2010.09.017","article-title":"ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration","volume":"300","author":"Mack","year":"2011","journal-title":"Cancer Lett"},{"key":"R39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/cdd.2010.153","article-title":"GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria","volume":"18","author":"John","year":"2011","journal-title":"Cell Death Differ"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Salmon P, Trono D. Production and titration of lentiviral vectors. Curr Protoc Hum Genet 2007; Chapter 12:Unit 12.10.","DOI":"10.1002\/0471142905.hg1210s54"},{"key":"R41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00018-009-0222-0","article-title":"Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death","volume":"67","author":"Engelmann","year":"2010","journal-title":"Cell Mol Life Sci"}],"container-title":["Cell Cycle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/cc.21476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T17:54:38Z","timestamp":1562090078000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/cc.21476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":41,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2012,8,15]]}},"alternative-id":["10.4161\/cc.21476"],"URL":"https:\/\/doi.org\/10.4161\/cc.21476","relation":{},"ISSN":["1538-4101","1551-4005"],"issn-type":[{"value":"1538-4101","type":"print"},{"value":"1551-4005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}